methamphetamine has been researched along with topiramate in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Ait-Daoud, N; Dawes, MA; Johnson, BA; Liu, L; Roache, JD; Wallace, CL; Wang, XQ; Wells, LT | 2 |
| Ait-Daoud, N; Dawes, MA; Javors, MA; Johnson, BA; Liu, L; Roache, JD; Wallace, CL; Wang, XQ; Wells, LT | 1 |
| Benguettat, D; Khazaal, Y; Zullino, DF | 1 |
| Kitanaka, J; Kitanaka, N; Morita, Y; Takemura, M; Tatsuta, T | 1 |
| Ait-Daoud, N; Anderson, A; Campbell, J; Carlton, B; Chiang, N; Dickinson, R; Elkashef, A; Gorodetzky, C; Haning, W; Hrymoc, M; Iturriaga, E; Johnson, BA; Kahn, R; Li, MD; Li, SH; Mawhinney, J; McCann, M; McSherry, F; Pham, T; Rawson, R; Serpi, T; Stock, C; Weis, D; Weiss, D; Yu, E | 1 |
| Vocci, F | 1 |
| Ait-Daoud, N; Campbell, J; Carlton, B; Dickinson, R; Elkashef, A; Gorodetzky, C; Haning, W; Hrymoc, M; Iturriaga, E; Johnson, BA; Li, MD; Ma, JZ; Mawhinney, J; McCann, M; McSherry, F; Pham, T; Rawson, RA; Saadvandi, J; Stock, C; Weis, D; Weiss, D; Yu, E | 1 |
| Ait-Daoud, N; Campbell, J; Elkashef, A; Haning, W; Iturriaga, E; Johnson, BA; Kahn, R; Li, MD; Ma, JZ; Mawhinney, DJ; McCann, M; Morris, R; Niu, T; Saadvandi, J; Seneviratne, C; Stock, C; Wang, J; Weis, D; Weiss, D; Yu, E | 1 |
| Ghaderi, E; Hamidi, S; Hassanzadeh, K; Mardani, R; Rezaei, F | 1 |
| Ciccarone, D; Shoptaw, S | 1 |
2 review(s) available for methamphetamine and topiramate
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Understanding Stimulant Use and Use Disorders in a New Era.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adult; Anticonvulsants; Behavior Therapy; Bupropion; Central Nervous System Stimulants; Cocaine-Related Disorders; Cognitive Dysfunction; Comorbidity; Dopamine Uptake Inhibitors; Female; Humans; Illicit Drugs; Male; Mental Disorders; Methamphetamine; Mirtazapine; Neurobiology; Neurodegenerative Diseases; Opiate Overdose; Substance Withdrawal Syndrome; Topiramate; Transgender Persons; United States | 2022 |
6 trial(s) available for methamphetamine and topiramate
| Article | Year |
|---|---|
Effects of acute topiramate dosing on methamphetamine-induced subjective mood.
Topics: Adult; Affect; Amphetamine-Related Disorders; Behavior, Addictive; Central Nervous System Stimulants; Cross-Over Studies; Dopamine Agents; Dopamine Antagonists; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Fructose; Humans; Male; Methamphetamine; Reinforcement, Psychology; Surveys and Questionnaires; Topiramate | 2007 |
Kinetic and cardiovascular effects of acute topiramate dosing among non-treatment-seeking, methamphetamine-dependent individuals.
Topics: Adult; Amphetamine-Related Disorders; Area Under Curve; Cardiovascular System; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Female; Fructose; Humans; Male; Methamphetamine; Neuroprotective Agents; Time Factors; Topiramate | 2007 |
Topiramate for the treatment of methamphetamine addiction: a multi-center placebo-controlled trial.
Topics: Adult; Amphetamine-Related Disorders; Double-Blind Method; Excitatory Amino Acid Antagonists; Female; Fructose; GABA Agents; Humans; Male; Medication Adherence; Methamphetamine; Middle Aged; Psychometrics; Topiramate; Treatment Outcome; Young Adult | 2012 |
Fine-grain analysis of the treatment effect of topiramate on methamphetamine addiction with latent variable analysis.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Behavior, Addictive; Female; Fructose; Humans; Male; Methamphetamine; Middle Aged; Time Factors; Topiramate; Treatment Outcome; Young Adult | 2013 |
Transcriptome profiling and pathway analysis of genes expressed differentially in participants with or without a positive response to topiramate treatment for methamphetamine addiction.
Topics: Amphetamine-Related Disorders; Behavior, Addictive; Biomarkers; Central Nervous System Stimulants; Databases, Factual; Double-Blind Method; Fructose; Gene Expression Profiling; Humans; Methamphetamine; Neuroprotective Agents; Oligonucleotide Array Sequence Analysis; Signal Transduction; Topiramate | 2014 |
Topiramate for the management of methamphetamine dependence: a pilot randomized, double-blind, placebo-controlled trial.
Topics: Adult; Amphetamine-Related Disorders; Central Nervous System Stimulants; Disease Management; Double-Blind Method; Follow-Up Studies; Fructose; Humans; Iran; Male; Methamphetamine; Pilot Projects; Topiramate | 2016 |
5 other study(ies) available for methamphetamine and topiramate
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Effects of topiramate on methamphetamine-induced changes in attentional and perceptual-motor skills of cognition in recently abstinent methamphetamine-dependent individuals.
Topics: Adult; Amphetamine-Related Disorders; Area Under Curve; Attention; Central Nervous System Stimulants; Cognition Disorders; Dose-Response Relationship, Drug; Female; Fructose; Humans; Male; Methamphetamine; Neuroprotective Agents; Psychiatric Status Rating Scales; Psychomotor Performance; Substance Abuse, Intravenous; Topiramate; Visual Perception | 2007 |
Improvement of cognitive performance by topiramate: Blockage of automatic processes may be the underlying mechanism.
Topics: Amphetamine-Related Disorders; Autonomic Nerve Block; Cognition; Fructose; Humans; Methamphetamine; Neuroprotective Agents; Topiramate | 2007 |
Lack of effect of anticonvulsant topiramate on methamphetamine-induced stereotypy and rewarding property in mice.
Topics: Animals; Anticonvulsants; Central Nervous System Stimulants; Conditioning, Operant; Dopamine; Dose-Response Relationship, Drug; Fructose; Homovanillic Acid; Male; Methamphetamine; Mice; Mice, Inbred ICR; Motor Activity; Neostriatum; Nucleus Accumbens; Reward; Stereotyped Behavior; Topiramate | 2007 |
Commentary on Elkashef et al. (2012): just enough efficacy for a second look.
Topics: Amphetamine-Related Disorders; Excitatory Amino Acid Antagonists; Female; Fructose; GABA Agents; Humans; Male; Methamphetamine; Topiramate | 2012 |